Next month’s in-depth feature story over at the National Cancer Institute’s Alliance for Nanotechnology in Cancer is about the opportunities that nanotechnology can offer in RNA silencing, a recently discovered mechanism that regulates translation of genetic material into protein. RNA silencing via nanodelivered double-stranded small interfering RNA (siRNA) molecules can offer a number of possibilities in treating cancer, autoimmune disorders and other diseases. As usual, the monthly feature story is not technical and is an easy and interesting read. Link…